Li-Fang Yu

1.9k total citations
63 papers, 1.4k citations indexed

About

Li-Fang Yu is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Li-Fang Yu has authored 63 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 17 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Li-Fang Yu's work include Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (10 papers) and Nicotinic Acetylcholine Receptors Study (9 papers). Li-Fang Yu is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (12 papers), Receptor Mechanisms and Signaling (10 papers) and Nicotinic Acetylcholine Receptors Study (9 papers). Li-Fang Yu collaborates with scholars based in China, United States and Australia. Li-Fang Yu's co-authors include Jia Li, Fan Yang, Fajun Nan, Hendra Gunosewoyo, Jie Tang, Tao Pang, Alan P. Kozikowski, Ronald J. Lukas, Beiying Qiu and J. Brek Eaton and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Li-Fang Yu

62 papers receiving 1.4k citations

Peers

Countries citing papers authored by Li-Fang Yu

Since Specialization

Citations

This map shows the geographic impact of Li-Fang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li-Fang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li-Fang Yu more than expected).

Fields of papers citing papers by Li-Fang Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li-Fang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li-Fang Yu. The network helps show where Li-Fang Yu may publish in the future.

Co-authorship network of co-authors of Li-Fang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Li-Fang Yu. A scholar is included among the top collaborators of Li-Fang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li-Fang Yu. Li-Fang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure-Based Development of 3,4-Fused Tricyclic Benzofuran Derivatives as Polyketide Synthase 13 Inhibitors with Negligible hERG Inhibition 2025 ·Journal of Medicinal Chemistry ·(unknown), Shichun Lun, Wei Zhang, (unknown), (unknown), Fan Yang, Jie Tang, William R. Bishai, Li-Fang Yu	1
2	Design, synthesis, and biological evaluations of 5-aryl-pyrazole-3-carboxamide derivatives as selective CB2 receptor agonists for the treatment of colitis 2024 ·European Journal of Medicinal Chemistry ·(unknown), Ying He, Jie Chen, Xianxing Jiang, Zhijun Qiu, (unknown), Xiang Gao, Hankun Zhang, H. L. Tian, Mingyao Liu, Weiqiang Lü, Li-Fang Yu	1
3	Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis 2024 ·European Journal of Medicinal Chemistry ·Xuan Zhang, Shichun Lun, Yuxin Li, Wei Zhang, (unknown), Ting Liu, Fan Yang, Jie Tang, William R. Bishai, Li-Fang Yu	2
4	Structure-directed identification of pyridine-2-methylamine derivatives as MmpL3 inhibitors for use as antitubercular agents 2023 ·European Journal of Medicinal Chemistry ·(unknown), Shichun Lun, (unknown), Wei Zhang, Ting Liu, (unknown), Jie Tang, William R. Bishai, Li-Fang Yu	8
5	Design, synthesis, and biological evaluation of 1,2,4-triazole derivatives as potent antitubercular agents 2023 ·Chinese Chemical Letters ·(unknown), Shichun Lun, (unknown), Wei Zhang, Tianyu Hu, Ting Liu, (unknown), Jie Tang, Bing Zhang, William R. Bishai, Li-Fang Yu	11
6	Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells 2021 ·RSC Medicinal Chemistry ·Shahinda S. R. Alsayed, (unknown), (unknown), (unknown), Eryn L. Werry, Chiang‐Ching Huang, Li-Fang Yu, Michael Kassiou, Simone Treiger Sredni, Hendra Gunosewoyo	4
7	CircWEE1/miR-138 axis promotes the malignant progression of glioma by regulating SIRT1 2021 ·Translational Cancer Research ·Jinhui Guo, Li-Fang Yu	6
8	Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules 2021 ·European Journal of Medicinal Chemistry ·Wei Zhang, (unknown), Shichun Lun, (unknown), (unknown), Hendra Gunosewoyo, Fan Yang, Jie Tang, William R. Bishai, Li-Fang Yu	25
9	Introducing nitrogen atoms to amidoalkylindoles: potent and selective cannabinoid type 2 receptor agonists with improved aqueous solubility 2019 ·MedChemComm ·(unknown), Zhilong Wang, (unknown), (unknown), (unknown), Hendra Gunosewoyo, Fan Yang, Jie Tang, Xin Xie, Li-Fang Yu	9
10	Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives 2019 ·Bioorganic & Medicinal Chemistry Letters ·Zhicheng Wang, Jing Wang, Chen Huang, Jie Tang, (unknown), Ting Liu, Li-Fang Yu, Zhengfang Yi, Fan Yang	24
11	Discovery of benzofuran-3(2 H )-one derivatives as novel DRAK2 inhibitors that protect islet β-cells from apoptosis 2017 ·European Journal of Medicinal Chemistry ·(unknown), Lei Xu, Yuting Lu, Yufei Liu, Bing Han, Ting Liu, Jie Tang, Jia Li, (unknown), Jiangping Wu, Jingya Li, Li-Fang Yu, Fan Yang	39
12	The synthesis and antistaphylococcal activity of 9, 13-disubstituted berberine derivatives 2017 ·European Journal of Medicinal Chemistry ·Jing Wang, Teng Yang, Chenyang Huang, (unknown), Li-Fang Yu, Ting Liu, Jie Tang, Zhengfang Yi, Cai‐Guang Yang, Wei Xue, Fan Yang	50
13	Synthesis and biological evaluation of novel hybrids of highly potent and selective α4β2-Nicotinic acetylcholine receptor (nAChR) partial agonists 2016 ·European Journal of Medicinal Chemistry ·(unknown), J. Brek Eaton, Allison Fedolak, Hendra Gunosewoyo, Oluseye K. Onajole, Dani Brunner, Ronald J. Lukas, Li-Fang Yu, Alan P. Kozikowski	10
14	Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies 2014 ·Genetics and Molecular Research ·(unknown), Dongxian Jiang, (unknown), (unknown), (unknown), Li-Fang Yu	5
15	Formyl Peptide Receptor Suppresses Melanoma Development and Promotes NK Cell Migration 2014 ·Inflammation ·Jian Liu, Jun Li, Xiang Zeng, Zhiguo Rao, Jianfei Gao, Bicheng Zhang, Yong Zhao, Bo Yang, Zhigang Wang, Li-Fang Yu, Weixing Wang	13
16	Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer 2013 ·Oncology Reports ·Yafei Zhang, Bicheng Zhang, (unknown), Tingting Wu, Jian Li, Li-Fang Yu, Weixing Wang, Jianfei Gao, Dian-Chun Fang, Zhiguo Rao	21
17	1H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis 2012 ·Experimental and Therapeutic Medicine ·Zhigang Wang, Zhe Chen, Sisi Yang, Yu Wang, Li-Fang Yu, Bicheng Zhang, Zhiguo Rao, Jianfei Gao, Shenghao Tu	62
18	Pharmacokinetics and brain penetration of LF-3-88, (2-[5-[5-(2(S)-azetidinylmethoxyl)-3-pyridyl]-3-isoxazolyl]ethanol), a selective α4β2-nAChR partial agonist and promising antidepressant 2012 ·Journal of Chromatography B ·Yuan Yang, Li-Fang Yu, Xi Qiu, Alan P. Kozikowski, Richard B. van Breemen	2
19	AMPK Activators as Novel Therapeutics for Type 2 Diabetes 2010 ·Current Topics in Medicinal Chemistry ·Li-Fang Yu, Beiying Qiu, Fajun Nan, Jia Li	40
20	AMP-activated Protein Kinase Is Involved in Neural Stem Cell Growth Suppression and Cell Cycle Arrest by 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside and Glucose Deprivation by Down-regulating Phospho-retinoblastoma Protein and Cyclin D 2009 ·Journal of Biological Chemistry ·Yi Zang, Li-Fang Yu, Fajun Nan, Linyin Feng, Jia Li	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact